Found 24 matching trials
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above PHASE3 The aim of this study is to assess the immunogenicity, safety and reactogen...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ā„65 Years of Age PHASE2 The present study is designed to confirm the safety and immunogenicity of t...
Show More Location
Antwerp University Centre for the Evaluation of Vaccination
Learn More & Join Trial
FLUADĀ® vs. FluzoneĀ® High-Dose Study PHASE4 The overall aim of the study is to compare safety and immunogenicity of ina...
Show More Location
Centers for Disease Control and Prevention
Learn More & Join Trial
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ā„65 Years N/A This study will evaluate the relative vaccine effectiveness of quadrivalent...
Show More Location
Kaiser Permanente Northern California (entire region)
Learn More & Join Trial
Senescent Immunity in Elders and Vaccine Responses (SILVER) PHASE4 To study the effects of age on the immune system's response to flu vaccine ...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects PHASE2 To evaluate the antibody response to each influenza vaccine antigen when ad...
Show More Location
Dipartimento di Medicina e Scienze dell'Invecchiamento
Learn More & Join Trial
Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses PHASE4 The purpose of this protocol is to generate a set of data that will be anal...
Show More Location
Center for Vaccinology
Learn More & Join Trial
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults PHASE4 This study will examine how various FDA-approved seasonal influenza vaccine...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age PHASE2 The objectives of this study were:
* To describe the safety of each dosage...
Show More Location
Investigational Site Number 8400004
Learn More & Join Trial
Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects PHASE3 The present study, phase III, randomized, controlled, observer-blind, multi...
Show More Location
Tampere Vaccine Research Clinic (15 sites)
Learn More & Join Trial